Skip to content
Open access

Pneumococcal vaccination status in critically ill patients: A cross-sectional study

Aug 2026 · Human Vaccines & Immunotherapeutics · Vol 22 · 0 citations · 28 references
Medicine

TL;DR

It is highlighted that most ICU patients were eligible for pneumococcal vaccination, but a minority of eligible patients reported vaccination, and approximately one-third had unknown vaccination status, which supports the need for more reliable vaccination records and routine opportunities in this population.

Abstract

ABSTRACT Critically ill adults are often older and have multiple chronic conditions, but data on prior pneumococcal vaccination in this population are limited. We aimed to assess pneumococcal vaccination coverage among eligible patients and identify factors associated with pneumococcal vaccination among ICU patients. We performed a cross-sectional study in an ICU at a tertiary care hospital in Japan. We included patients admitted to the ICU from May 15, 2023, to January 4, 2024. Eligibility for pneumococcal vaccination was defined with reference to the Japanese routine vaccination program during the study period. Vaccination status for pneumococcal, influenza, and coronavirus disease 2019 (COVID-19) vaccines was assessed using a structured questionnaire administered to patients or family members during ICU admission. Multivariable logistic regression analysis was performed among eligible patients with known pneumococcal vaccination status. Among 982 patients, 757 (77.1%) met pneumococcal vaccination eligibility criteria. After excluding 32 non-responders, vaccination status was assessed for 725 eligible patients. Of these, 124 (17.1%) reported pneumococcal vaccination, 371 (51.2%) reported no pneumococcal vaccination, and 230 (31.7%) reported unknown status. In the multivariable analysis, influenza vaccination was the only factor independently associated with reported pneumococcal vaccination status (odds ratio, 31.8, 95% confidence interval, 4.3–236.7, p < .001). Our study highlights that most ICU patients were eligible for pneumococcal vaccination, but a minority of eligible patients reported vaccination, and approximately one-third had unknown vaccination status. These findings support the need for more reliable vaccination records and routine opportunities to assess eligibility and history in this population.

Read PDF

Similar papers

Open access Sep 2026

Influenza and pneumococcal vaccination status and related factors in obese adults: a single-center cross-sectional study

Vaccination uptake among adults with obesity, particularly pneumococcal vaccination, may be improved by vaccine-specific counseling that emphasizes obesity-related infection risk, addresses safety concerns and information gaps, and supports clear vaccine recommendations during clinical encounters.

E. Türe, B. Yazıcıoğlu · 0 citations
Review Open access Sep 2026

Evaluation of post-vaccination pneumonia incidence in patients receiving pneumococcal vaccine administered by home health care services

Objective: Individuals receiving home health care services often constitute a group with multiple chronic conditions, limited physical mobility, and restricted access to healthcare facilities. Immunization services are therefore critical for preventing infections in this population. Therefore, this study aimed to evalu...

Osman Barak, Aybuke Bacanli, S. Arıca · 0 citations
Open access Sep 2026

Effectiveness of 20-valent pneumococcal conjugate vaccine against pneumococcal pneumonia hospitalizations among U.S. adults: Test-Negative Design

The findings support the importance of aligning pneumococcal vaccination strategies with regional serotype distribution to maximize vaccine impact and support the importance of aligning pneumococcal vaccination strategies with regional serotype distribution to maximize vaccine impact.

A. Ologunowa, S. Kogut, V. L. Vrishali et al. · 0 citations
Open access Sep 2026

Influenza Vaccination Status and Clinical Outcomes Among Adults Hospitalized with Community-Acquired Pneumonia: A Retrospective Cohort from Saudi Arabia

Background: Influenza vaccination is widely recommended to prevent influenza and its complications; however, its association with clinical outcomes among high-risk populations remains uncertain. This study aimed to investigate the association between influenza vaccination status and clinical outcomes among adults hospi...

Shouq M. Alzaaqi, A. Banjar, M. A. Almoghrabi et al. · 0 citations
Open access Sep 2026

Influenza and pneumococcal vaccination rates across FACED severity categories in bronchiectasis

Bronchiectasis is a chronic and heterogeneous airway disease in which prevention of exacerbations is a key component of management. Although influenza and pneumococcal vaccination are strongly recommended in this population, real-world vaccination rates remain suboptimal. Vaccination coverage across different lev...

Savaş Gegin, Burcu Özdemir, Esra Arslan Aksu et al. · 0 citations
Open access Sep 2026

RSV in Ontario hospitalized adults who would have been excluded from vaccine trials

This study aimed to describe the proportion of patients hospitalized for respiratory syncytial virus (RSV) infection who would have been excluded from RSV vaccine phase 3 trials, and to compare length-of-stay and in-hospital mortality between patients who would have been included versus excluded from these trials....

A. Bai, Siddhartha Srivastava, S. Buchan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.